Quarterly ResultMay 13, 2026, 06:13 AM
DarioHealth Raises Going Concern Doubt; Q1 Net Loss $8.25M
AI Summary
DarioHealth Corp. reported a net loss of $8.25 million for the first quarter of 2026, an improvement from $9.23 million in the prior year. However, the company disclosed substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows. Total revenues for the quarter decreased to $5.58 million, with a decline in services revenue partially offset by an increase in consumer hardware revenue. Cash and cash equivalents significantly decreased to $14.98 million by the end of the period.
Key Highlights
- DarioHealth raised substantial doubt about its ability to continue as a going concern.
- Q1 2026 net loss was $8.25 million, an improvement from $9.23 million in Q1 2025.
- Total revenues decreased to $5.58 million in Q1 2026 from $6.75 million in Q1 2025.
- Services revenue declined to $2.83 million, while consumer hardware revenue rose to $2.76 million.
- Net cash used in operating activities improved to $6.03 million from $6.67 million year-over-year.
- Cash and cash equivalents decreased to $14.98 million as of March 31, 2026.
- Warrant liability significantly decreased to $23 thousand from $1.47 million as of December 31, 2025.
- Final tranche of Pre-Funded Warrants related to Twill acquisition was cashless exercised in Q1 2026.